Abrogate Pharma LLP
About Abrogate Pharma LLP
Data last updated:
Abrogate Pharma LLP is a limited liability partnership (LLP) based in Jaipur, Rajasthan, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 21 August 2020 and has been in existence for over 6 years.
The LLP is registered with the Registrar of Companies (ROC), Jaipur, under LLPIN AAT-4347. The LLP has 1 GST registration on record, which is no longer active.
The LLP has a total obligation of contribution of ₹50,000. It is led by designated partners Neeraj Singh Ranawat and Vishali Swami.
Its latest statement of accounts is for the year ended 31 March 2022. The registered office is at 7 Ch 25 Jawahar Nagar, Jaipur, Rajasthan, India – 302004.
As per the financials filed for FY 2022, the LLP reported a revenue of ₹67.09 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.86 Lakh (net margin 2.8%) and EBITDA of -₹74.84 Lakh (EBITDA margin -111.5%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address7 Ch 25 Jawahar Nagar, Jaipur, Rajasthan, India – 302004
- IndustryChemicals, Manufacturing, Chemicals And Chemical Products
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Abrogate Pharma LLP FY 2022 filings available
Abrogate Pharma LLP reported revenue of ₹67.09 Lakh (up 882% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR) of Abrogate Pharma LLP
Revenue rose 882% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Abrogate Pharma LLP
| Statement of Account and Solvency | FY 2021-22 | FY 2020-21 |
|---|---|---|
| Income and Expenditure | ||
| Turnover | ₹67.09 Lakh | •••• |
| Other Income | •••• | •••• |
| Total Income | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• |
| Personnel Expenses | •••• | •••• |
| Administrative Expenses | •••• | •••• |
| Interest | •••• | •••• |
| Depreciation | •••• | •••• |
| Total Expenses | •••• | •••• |
| Profit Before Tax | •••• | •••• |
| Tax | •••• | •••• |
| Profit After Tax | ₹1.86 Lakh | •••• |
| Profit Transferred to Partners | •••• | •••• |
| Assets and Liabilities | ||
| Partners' Contribution | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Secured Loans | •••• | •••• |
| Unsecured Loans | •••• | •••• |
| Trade Payables | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Loans and Advances | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Abrogate Pharma LLP
| Statement of Account and Solvency | FY 2021-22 | FY 2020-21 |
|---|---|---|
| Profitability | ||
| Net Profit Margin | 2.8% | •••• |
| Return on Partners' Funds | •••• | •••• |
| Return on Assets | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• |
| Interest Coverage | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Turnover Growth | •••• | •••• |
| Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Abrogate Pharma are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Abrogate Pharma LLP
Abrogate Pharma has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neeraj Singh Ranawat | Designated Partner | 21 Aug 2020 | 6 Years 1 Months | Current |
| Vishali Swami | Designated Partner | 29 Oct 2020 | 5 Years 11 Months | Current |
Ownership and Shareholding of Abrogate Pharma LLP
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Abrogate Pharma LLP
Abrogate Pharma LLP does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Abrogate Pharma LLP
Employment history and EPFO contributions of people linked to Abrogate Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Abrogate Pharma LLP
Abrogate Pharma LLP has 2 designated partner changes on record since 2020: 2 appointments. The latest: Vishali Swami was appointed as Designated Partner on 29 Oct 2020.
Credit Ratings, Litigation & Regulatory Alerts for Abrogate Pharma LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Abrogate Pharma LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Abrogate Pharma LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Abrogate Pharma LLP
Abrogate Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Abrogate Pharma LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abrogate Pharma LLP
Abrogate Pharma is an active limited liability partnership based in Jaipur, Rajasthan, India. The LLP works in manufacturing, within the chemicals industry. It was incorporated on 21 August 2020 (6+ years old) and is registered under LLPIN AAT-4347.
Abrogate Pharma reported revenue of ₹67.09 Lakh for FY 2022 (up 882% YoY).
Abrogate Pharma has 2 current designated partners:
- Neeraj Singh Ranawat - Designated Partner
- Vishali Swami - Designated Partner
Abrogate Pharma reported a net profit of ₹1.86 Lakh (net margin 2.8%) and EBITDA of -₹74.84 Lakh (EBITDA margin -111.5%) for FY 2022, as per its filed financial statements.
No. Abrogate Pharma has 1 GST registration on record and it is cancelled or inactive.
The LLPIN (Limited Liability Partnership Identification Number) of Abrogate Pharma is AAT-4347. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Abrogate Pharma was incorporated on 21 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Jaipur.
Vishali Swami was appointed as Designated Partner on 29 Oct 2020. Neeraj Singh Ranawat was appointed as Designated Partner on 21 Aug 2020.
The registered office of Abrogate Pharma is at 7 Ch 25 Jawahar Nagar, Jaipur, Rajasthan, India – 302004.
The total obligation of contribution is ₹50,000.